Join
Live feed
·
INSIDERFilingvia Quantisnow
Senti Biosciences Inc. logo

Pres. & Chief Med. & Dev. Off. Rajangam Kanya was granted 78,363 shares, increasing direct ownership by 909% to 86,984 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SNTI· Senti Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNTI (Senti Biosciences Inc.) and more on Quantisnow.